These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 16705640)

  • 1. Three-dimensional modeling of cytomegalovirus DNA polymerase and preliminary analysis of drug resistance.
    Shi R; Azzi A; Gilbert C; Boivin G; Lin SX
    Proteins; 2006 Aug; 64(2):301-7. PubMed ID: 16705640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus.
    Chou S; Lurain NS; Thompson KD; Miner RC; Drew WL
    J Infect Dis; 2003 Jul; 188(1):32-9. PubMed ID: 12825168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different mutations in the HHV-6 DNA polymerase gene accounting for resistance to foscarnet.
    Bonnafous P; Naesens L; Petrella S; Gautheret-Dejean A; Boutolleau D; Sougakoff W; Agut H
    Antivir Ther; 2007; 12(6):877-88. PubMed ID: 17926642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opposite effect of two cytomegalovirus DNA polymerase mutations on replicative capacity and polymerase activity.
    Martin M; Azzi A; Lin SX; Boivin G
    Antivir Ther; 2010; 15(4):579-86. PubMed ID: 20587851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Piret J; Goyette N; Eckenroth BE; Drouot E; Götte M; Boivin G
    J Virol; 2015 Apr; 89(8):4636-44. PubMed ID: 25673718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the UL54 gene of human cytomegalovirus isolates that confers resistance to foscarnet.
    Ducancelle A; Champier G; Alain S; Petit F; Le Pors MJ; Mazeron MC
    Antivir Ther; 2006; 11(4):537-40. PubMed ID: 16856628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
    Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
    J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations conferring foscarnet resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis.
    Weinberg A; Jabs DA; Chou S; Martin BK; Lurain NS; Forman MS; Crumpacker C; ;
    J Infect Dis; 2003 Mar; 187(5):777-84. PubMed ID: 12599051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganciclovir resistance mutations in UL97 and UL54 genes of Human cytomegalovirus isolates resistant to ganciclovir.
    Foulongne V; Turrière C; Diafouka F; Abraham B; Lastere S; Segondy M
    Acta Virol; 2004; 48(1):51-5. PubMed ID: 15230476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of helix P of the human cytomegalovirus DNA polymerase in resistance and hypersusceptibility to the antiviral drug foscarnet.
    Tchesnokov EP; Gilbert C; Boivin G; Götte M
    J Virol; 2006 Feb; 80(3):1440-50. PubMed ID: 16415021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a non-radioactive DNA polymerase assay for studying cytomegalovirus resistance to foscarnet.
    Ducancelle A; Alain S; Petit F; Sanson Le Pors MJ; Mazeron MC
    J Virol Methods; 2007 May; 141(2):212-5. PubMed ID: 17197042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-center experience with ganciclovir-resistant cytomegalovirus in lung transplant recipients: treatment and outcome.
    Reddy AJ; Zaas AK; Hanson KE; Palmer SM
    J Heart Lung Transplant; 2007 Dec; 26(12):1286-92. PubMed ID: 18096480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance to combined ganciclovir and foscarnet therapy in a liver transplant recipient with possible dual-strain cytomegalovirus coinfection.
    Rodriguez J; Casper K; Smallwood G; Stieber A; Fasola C; Lehneman J; Heffron T
    Liver Transpl; 2007 Oct; 13(10):1396-400. PubMed ID: 17902124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of cytomegalovirus resistance to ganciclovir therapy in kidney transplant recipients.
    Nogueira E; Ozaki KS; Tomiyama H; Granato CF; Camara NO; Pacheco-Silva A
    Int Immunopharmacol; 2006 Dec; 6(13-14):2031-7. PubMed ID: 17161359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel DNA polymerase mutations conferring cytomegalovirus resistance: input of BAC-recombinant phenotyping and 3D model.
    Hantz S; Cotin S; Borst E; Couvreux A; Salmier A; Garrigue I; Merville P; Mengelle C; Attal M; Messerle M; Alain S
    Antiviral Res; 2013 Apr; 98(1):130-4. PubMed ID: 23415883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance.
    De Bolle L; Manichanh C; Agut H; De Clercq E; Naesens L
    Antiviral Res; 2004 Oct; 64(1):17-25. PubMed ID: 15451175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis.
    Andouard D; Mazeron MC; Ligat G; Couvreux A; Pouteil-Noble C; Cahen R; Yasdanpanah Y; Deering M; Viget N; Alain S; Hantz S
    Antiviral Res; 2016 May; 129():115-119. PubMed ID: 26872863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus ventriculoencephalitis in a peripheral blood stem cell transplant recipient.
    Miller GG; Boivin G; Dummer JS; McConnell T; Becher MW; Kassim A; Tang YW
    Clin Infect Dis; 2006 Feb; 42(4):e26-9. PubMed ID: 16421783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A novel colorimetric test to study the susceptibility of human cytomegalovirus DNA polymerase to foscarnet].
    Ducancelle A; Alain S; Scieux C; Fillet AM; Petit F; Sanson-Le Pors MJ; Mazeron MC
    Pathol Biol (Paris); 2005; 53(8-9):551-5. PubMed ID: 16084026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypersusceptibility of Human Cytomegalovirus to Foscarnet Induced by Mutations in Helices K and P of the Viral DNA Polymerase.
    Zarrouk K; Pham VD; Piret J; Shi R; Boivin G
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.